DMP.DE
Price:
$36.5
Market Cap:
$1.97B
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Al...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-04-12
Stock Exchange
XETRA
Ticker
DMP.DE
According to Dermapharm Holding SE’s latest financial reports and current stock price. The company's current PE Ratio is 17.30. This represents a change of 9.17% compared to the average of 15.85 of the last 4 quarters.
The mean historical PE Ratio of Dermapharm Holding SE over the last ten years is 37.75. The current 17.30 PE Ratio has changed 4.48% with respect to the historical average. Over the past ten years (40 quarters), DMP.DE's PE Ratio was at its highest in in the December 2016 quarter at 58.71. The PE Ratio was at its lowest in in the December 2023 quarter at -211.54.
Average
37.75
Median
25.33
Minimum
15.05
Maximum
110.21
Discovering the peaks and valleys of Dermapharm Holding SE PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 142.88%
Maximum Annual PE Ratio = 110.21
Minimum Annual Increase = -100.48%
Minimum Annual PE Ratio = 15.05
Year | PE Ratio | Change |
---|---|---|
2024 | 18.45 | -49.53% |
2023 | 36.55 | 142.88% |
2022 | 15.05 | -34.40% |
2021 | 22.94 | -35.80% |
2020 | 35.73 | 28.89% |
2019 | 27.72 | 63.02% |
2018 | 17.01 | 1.83% |
2017 | 16.70 | -78.36% |
2016 | 77.17 | -29.98% |
2015 | 110.21 | -100.48% |
The current PE Ratio of Dermapharm Holding SE (DMP.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
23.35
5-year avg
25.74
10-year avg
37.75
Dermapharm Holding SE’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dermapharm Holding SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Dermapharm Holding SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Dermapharm Holding SE's PE Ratio?
How is the PE Ratio calculated for Dermapharm Holding SE (DMP.DE)?
What is the highest PE Ratio for Dermapharm Holding SE (DMP.DE)?
What is the 3-year average PE Ratio for Dermapharm Holding SE (DMP.DE)?
What is the 5-year average PE Ratio for Dermapharm Holding SE (DMP.DE)?
How does the current PE Ratio for Dermapharm Holding SE (DMP.DE) compare to its historical average?